Information  X 
Enter a valid email address

Avacta Group PLC Ord 10P (AVCT)

Date Time Source Announcement
14 Oct 2021 4:36 pm
RNS
Price Monitoring Extension
  12:36 pm
RNS
Issue of Equity and Total Voting Rights
30 Sep 2021 7:00 am
RNS
Interim Results for the Period Ended 30 June 2021
29 Sep 2021 7:00 am
RNS
Development Milestone in LG Chem Partnership
22 Sep 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
09 Sep 2021 7:00 am
RNS
Notice of Results
06 Sep 2021 7:00 am
RNS
New appointments to Scientific Advisory Board
02 Sep 2021 7:00 am
RNS
Appointment of Chief Scientific Officer
25 Aug 2021 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
18 Aug 2021 7:00 am
RNS
Directorate Change
11 Aug 2021 7:00 am
RNS
First Patient Dosed in AVA6000 Phase 1 Trial
04 Aug 2021 7:00 am
RNS
Update on AffiDX Lateral Flow Test
14 Jul 2021 7:00 am
RNS
Diagnostics achieves ISO 13485 Certification
12 Jul 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
29 Jun 2021 7:00 am
RNS
AffiDX Lateral Flow Test Detects Delta Variant
28 Jun 2021 12:13 pm
RNS
Result of AGM
21 Jun 2021 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
AffiDX Lateral Flow Test Distribution Agreement
15 Jun 2021 8:00 am
RNS
Issue of Equity and Total Voting Rights
11 Jun 2021 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:07 am
RNS
Registration of AffiDX Lateral Flow Test in EU
09 Jun 2021 9:08 am
RNS
Holding(s) in Company
07 Jun 2021 7:00 am
RNS
MHRA Confirms Registration of Lateral Flow Test
01 Jun 2021 7:00 am
RNS
Update on Lateral Flow Test Regulatory Submissions
28 May 2021 7:00 am
RNS
Response to speculation
25 May 2021 10:00 am
RNS
Posting of Annual Report and Notice of AGM
10 May 2021 10:36 am
RNS
AffiDX SARS-CoV-2 Antigen Lateral Flow Test Update
06 May 2021 7:00 am
RNS
Change of Nominated Adviser
30 Apr 2021 12:37 pm
RNS
Issue of Equity
28 Apr 2021 5:18 pm
RNS
Issue of Equity
  4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
22 Apr 2021 7:00 am
RNS
Final Results
20 Apr 2021 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Clinical validation of AffiDX Lateral Flow Test
15 Apr 2021 4:36 pm
RNS
Price Monitoring Extension
13 Apr 2021 7:00 am
RNS
Notice of Results and Investor Presentation
12 Apr 2021 1:30 pm
RNS
Issue of Equity
06 Apr 2021 7:00 am
RNS
Distribution Agreement with ABCAM plc
25 Mar 2021 3:01 pm
RNS
Directorate Change
16 Mar 2021 5:08 pm
RNS
Issue of Equity
15 Mar 2021 5:22 pm
RNS
Issue of Equity
09 Mar 2021 7:00 am
RNS
Diagnostic Licensing Deal with Biokit
08 Mar 2021 7:00 am
RNS
Rapid Antigen Test Detects SARS-CoV-2 Variants
03 Mar 2021 5:14 pm
RNS
Electronic Communications with Shareholders
24 Feb 2021 7:00 am
RNS
Business Update
22 Feb 2021 7:00 am
RNS
Re: Press Speculation
18 Feb 2021 7:00 am
RNS
Phase I CTA for AVA6000 Approved by MHRA
16 Feb 2021 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Results of Initial Evaluation of SARS-CoV-2 LFT
08 Feb 2021 7:00 am
RNS
Commercial Partnership with Mologic
02 Feb 2021 8:30 am
RNS
Issue of Equity
01 Feb 2021 7:00 am
RNS
AffyXell $7.3 Million Series A Financing

a d v e r t i s e m e n t